These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 34291563

  • 1. SD-36 promotes growth inhibition and induces apoptosis via suppression of Mcl-1 in glioma.
    Kong S, Ge X, Li X, Liu Z, Zhang R, Yang M, Wang Z, Li Z.
    J Cell Mol Med; 2021 Sep; 25(17):8261-8270. PubMed ID: 34291563
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo.
    Iwamaru A, Szymanski S, Iwado E, Aoki H, Yokoyama T, Fokt I, Hess K, Conrad C, Madden T, Sawaya R, Kondo S, Priebe W, Kondo Y.
    Oncogene; 2007 Apr 12; 26(17):2435-44. PubMed ID: 17043651
    [Abstract] [Full Text] [Related]

  • 4. Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein.
    Zhou H, Bai L, Xu R, Zhao Y, Chen J, McEachern D, Chinnaswamy K, Wen B, Dai L, Kumar P, Yang CY, Liu Z, Wang M, Liu L, Meagher JL, Yi H, Sun D, Stuckey JA, Wang S.
    J Med Chem; 2019 Dec 26; 62(24):11280-11300. PubMed ID: 31747516
    [Abstract] [Full Text] [Related]

  • 5. Oxaliplatin disrupts pathological features of glioma cells and associated macrophages independent of apoptosis induction.
    Roberts NB, Alqazzaz A, Hwang JR, Qi X, Keegan AD, Kim AJ, Winkles JA, Woodworth GF.
    J Neurooncol; 2018 Dec 26; 140(3):497-507. PubMed ID: 30132163
    [Abstract] [Full Text] [Related]

  • 6. Bortezomib-induced sensitization of malignant human glioma cells to vorinostat-induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl-1 cleavage, and DNA damage.
    Premkumar DR, Jane EP, Agostino NR, DiDomenico JD, Pollack IF.
    Mol Carcinog; 2013 Feb 26; 52(2):118-33. PubMed ID: 22086447
    [Abstract] [Full Text] [Related]

  • 7. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
    Li H, Chen L, Li JJ, Zhou Q, Huang A, Liu WW, Wang K, Gao L, Qi ST, Lu YT.
    J Hematol Oncol; 2018 May 29; 11(1):70. PubMed ID: 29843746
    [Abstract] [Full Text] [Related]

  • 8. Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells.
    Gu J, Li G, Sun T, Su Y, Zhang X, Shen J, Tian Z, Zhang J.
    J Neurooncol; 2008 Aug 29; 89(1):9-17. PubMed ID: 18415045
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells.
    Ciaglia E, Torelli G, Pisanti S, Picardi P, D'Alessandro A, Laezza C, Malfitano AM, Fiore D, Pagano Zottola AC, Proto MC, Catapano G, Gazzerro P, Bifulco M.
    Oncotarget; 2015 Jun 20; 6(17):15464-81. PubMed ID: 26008966
    [Abstract] [Full Text] [Related]

  • 12. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.
    Duan Z, Bradner J, Greenberg E, Mazitschek R, Foster R, Mahoney J, Seiden MV.
    Mol Pharmacol; 2007 Nov 20; 72(5):1137-45. PubMed ID: 17675586
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.
    Wang H, Tao Z, Feng M, Li X, Deng Z, Zhao G, Yin H, Pan T, Chen G, Feng Z, Li Y, Zhou Y.
    Biochem Biophys Res Commun; 2020 Dec 10; 533(3):368-375. PubMed ID: 32962858
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma.
    Miklossy G, Youn UJ, Yue P, Zhang M, Chen CH, Hilliard TS, Paladino D, Li Y, Choi J, Sarkaria JN, Kawakami JK, Wongwiwatthananukit S, Chen Y, Sun D, Chang LC, Turkson J.
    J Med Chem; 2015 Oct 08; 58(19):7734-48. PubMed ID: 26331426
    [Abstract] [Full Text] [Related]

  • 18. Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent Manner.
    Kiprianova I, Remy J, Milosch N, Mohrenz IV, Seifert V, Aigner A, Kögel D.
    Neoplasia; 2015 Jul 08; 17(7):564-73. PubMed ID: 26297434
    [Abstract] [Full Text] [Related]

  • 19. Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells.
    Swiatek-Machado K, Mieczkowski J, Ellert-Miklaszewska A, Swierk P, Fokt I, Szymanski S, Skora S, Szeja W, Grynkiewicz G, Lesyng B, Priebe W, Kaminska B.
    Cancer Biol Ther; 2012 Jun 08; 13(8):657-70. PubMed ID: 22555804
    [Abstract] [Full Text] [Related]

  • 20. Stat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma.
    Pan Y, Zhou F, Zhang R, Claret FX.
    PLoS One; 2013 Jun 08; 8(1):e54565. PubMed ID: 23382914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.